Infographic on The Critical Role of Etiologic Investigation in Acute Ischemic Stroke
02 Feb 2026Infographic created in BioRender, C, A. (2025), © World Stroke Organization, sponsored by Bristol Myers Squibb and Johnson & Johnson
Infographic created in BioRender, C, A. (2025), © World Stroke Organization, sponsored by Bristol Myers Squibb and Johnson & Johnson
Infographic created in BioRender, C, A. (2025), © World Stroke Organization, sponsored by Bristol Myers Squibb and Johnson & Johnson
Introduction
Ischemic stroke is a heterogeneous condition with multiple underlying causes, each associated with distinct risk factors, mechanisms, and implications for secondary prevention. Accurate identification of stroke etiology is a cornerstone of effective management, as it directly informs diagnostic pathways, therapeutic decisions, and long-term prevention strategies.
To support healthcare professionals in understanding this complexity, the World Stroke Academy has developed an educational infographic titled “Beyond The Clot: Understanding Ischemic Stroke Etiology.” The infographic offers a clear, visual overview of the main etiological subtypes of ischemic stroke and highlights their relative contribution to global stroke burden.
Key educational themes
By presenting essential concepts in a concise and accessible format, the infographic aims to reinforce foundational knowledge and support a structured approach to stroke classification in clinical practice. This educational resource is designed to complement existing classification systems and guidelines, while encouraging ongoing education in an area that remains critical to improving patient outcomes.
Educational grant disclosure
This infographic was sponsored by Bristol Myers Squibb and Johnson & Johnson.
#FactorXIa inhibitors could reshape secondary stroke prevention🧠
🎥 @WorldStrokeEd Webinar + 📊Infographic
🌍Now available in multiple languages
Explore here: https://www.world-stroke-academy.org/news/factor-xia-inhibitors-a-new-paradigm-in-secondary-stroke-prevention/
#StrokeEducation #Neurology @Bayer
#MondayTip
#Tenecteplase may help—even when the artery stays closed.
In #TRACE3 (4.5–24h window), pts without recanalization still had better outcomes (42% vs 30%). Strongest effect in NIHSS ≥10.
👉 Think beyond large vessel reopening
https://doi.org/10.1186/s12916-026-04877-x
🎙️In the final episode of our Spasticity Unlocked series we shift the focus to what matters most: 𝐭𝐡𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭.
Dr. Stevens is joined by Gerard Sewell, offering a powerful & personal perspective on navigating life with #spasticity.
🔢Episodes: https://shorturl.at/F2QYE
#MondayTip
Can we prevent stroke without increasing bleeding?
Factor XIa inhibition #asundexian :
🔹⬇️recurrent stroke (HR 0.74)
🔸with no ⬆️major bleeding in OCEANIC-STROKE.
A potential shift in secondary prevention. 🧠⚖️
🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa2513880
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
